Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recommended
5 On Your Side shares 7 simple ways to cut down your energy bill this summer
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enliven Therapeutics, Inc. - Common Stock
(NQ:
ELVN
)
20.47
-1.09 (-5.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
202,679
Open
21.42
Bid (Size)
20.00 (1)
Ask (Size)
23.47 (1)
Prev. Close
21.56
Today's Range
20.39 - 22.47
52wk Range
9.800 - 26.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024
May 14, 2024
ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
April 11, 2024
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data.
Via
Benzinga
Performance
YTD
+37.38%
+37.38%
1 Month
-14.71%
-14.71%
3 Month
+16.70%
+16.70%
6 Month
+62.20%
+62.20%
1 Year
-6.06%
-6.06%
More News
Read More
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
April 09, 2024
Via
Benzinga
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Via
Benzinga
Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins
March 19, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
Via
Benzinga
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
August 17, 2023
Via
InvestorPlace
Bears Reload On Mobileye After Sharp Gains In Stock Price
May 28, 2023
Via
Talk Markets
7 Biotech Stocks Sitting in the Sweet Spot
March 24, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
March 03, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.